Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase IIa trial of BC007

Trial Profile

A Phase IIa trial of BC007

Phase of Trial: Phase II/III

Latest Information Update: 23 May 2018

At a glance

  • Drugs BC 007 (Primary)
  • Indications Dilated cardiomyopathy
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 May 2018 According to a Berlin Cures media release, this study will begin this July 2018.
    • 05 Mar 2018 New trial record
    • 26 Feb 2018 According to a Berlin Cures media release, Company plans to begin Phase II clinical testing of BC007 in the second quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top